Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | GJB2 | P29033 | 5/20 | 0.44 |
| ▸ | HRAS | P01112 | 1/20 | 0.41 |
| ▸ | MAG | P20916 | 1/20 | 0.40 |
| ▸ | GJA1 | P17302 | 4/20 | 0.39 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GALK1 | P51570 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16153930 | 0.88 | MAG (0.52) | SLC6A2HRASMAGPOLB | |
| SCHEMBL6567769 | 0.82 | L3MBTL1 (0.39) | SLC6A2GJB2HRAS | |
| SCHEMBL10831460 | 0.82 | L3MBTL1 (0.39) | SLC6A2GJB2HRAS | |
| SCHEMBL15028536 | 0.82 | GJB2 (0.46) | GJB2GJA1SYNJ2 | |
| SCHEMBL15012689 | 0.81 | SLC6A2 (0.58) | SLC6A2GJB2HRASGJA1SYNJ2 | |
| SCHEMBL16153924 | 0.81 | SLC6A2 (0.58) | SLC6A2GJB2HRASGJA1SYNJ2 | |
| SCHEMBL16146188 | 0.81 | SLC6A2 (0.58) | SLC6A2GJB2HRASGJA1SYNJ2 | |
| SCHEMBL7154934 | 0.79 | MEN1 (0.41) | SLC6A2 | |
| SCHEMBL1647584 | 0.74 | SSTR1 (0.45) | SLC6A2GJB2GJA1 | |
| SCHEMBL12650358 | 0.74 | MEN1 (0.40) | SLC6A2HRASSYNJ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GLYCOM A/S (DK) | 2014-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GALE, B4GALT1, GNE | SLC6A2 3154/4885GJB2 1285/4885HRAS 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.